FDA approves first rapid-acting insulin biosimilar for patients with diabetes
Aventis's Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with ...
Seeking Alpha26d
AbbVie: Q4 2024 Earnings Preview And Update On Emraclidine
The company is handling the erosion of Humira quite well ... but revenues were just $10 million above the low end of my $14.45-14.85 billion estimate range. However, that was still a good result ...
The Lancet28d
Stopping of adalimumab in juvenile idiopathic arthritis-associated uveitis (ADJUST): a multicentre, double-masked, randomised controlled trial
aFrancis I Proctor Foundation, University of California San Francisco, San Francisco, CA, USA bDepartment of Ophthalmology, University of California San Francisco, San Francisco, CA, USA cDepartment ...